EVOQ REMEDIES-MT Cash Flow Annual

Trade
BSE: 543500 | NSE: - | ISIN: INE0JVD01011 | Sector: Biotechnology & Drugs
11.20 +0.09 (0.81%)Updated : 12 Apr 2024
Fiscal Period2023202220212020
Period End DateMar 23Mar 22Mar 21Mar 20
Net Income/ Starting Line 2.281.460.720.00
Depreciation/ Depletion 0.000.000.000.00
Deferred Taxes 0.000.000.00-
Non- Cash Items 0.000.000.000.00
Changesin Working Capital -6.64-27.89-0.68-0.02
Cashfrom Operating Activities -4.35-26.430.03-0.02
Capital Expenditures -0.010.000.000.00
Other Investing Cash Flow Items Total 0.000.000.000.00
Cashfrom Investing Activities -0.010.000.000.00
Financing Cash Flow Items 0.000.000.00-
Issuance( Retirement)of Stock Net 0.0021.330.00-
Issuance( Retirement)of Debt Net 1.428.160.000.00
Cashfrom Financing Activities 1.4229.490.000.00
Net Changein Cash -2.943.060.03-0.02
Cash Interest Paid 0.000.000.00-
Cash Taxes Paid 0.670.370.000.00
*All figures in crores except per share values
Recommended For You
Trending Stocks
1,019.95+6.80(0.67%)
2,536.15+9.45(0.37%)
12,274.60-402.35 (-3.17%)